1 Medicina ortomoleculara in preventia si tratamentul
bolilor prin administrarea de produse cu specific ortomolecular, suplimente
nutritionale ca anti-cancer dupa diagnosticul
de cancer, sistematic reviu
2 Vitamine pentru preventia bolilor cronice la adulti, aplicatii
clinice, reviu stiintific
3 Suplimente nutritionale cu Multivitamine Minerale si preventia
de boli cronice
Termenul ortomolecular a fost folosit prima data de Linus
Pauling
4 Vitamine Antioxidante pentru preventia de boli cardiovasculare,
studiu randomizat dublu orb placebo controlat
5 Vitamine cu mega doza la cancerul de vezica urinara,
studiu randomizat placebo controlat
6 Terapia de Vitamine cu doza inalta stimuleaza enzimele
relevante in bolile genetice
7 Multivitamine si acid folic la cancerul de colon
8 Acid
Folic in preventia de cancer mamar
9 Vitamina D si Calciu
reduce riscul de cancer, studiu randomizat dublu orb placebo controlat.
10 Seleniu in preventia de cancer, reviu
si mecanism de actiune
29 L-Arginina cu efect metabolic si imunologic la cancer
30 Suplimente nutritive cu Vitamina C ca suport la boala de
cancer si prelungirea supravietuirii umane
L-Lizina inhiba colagenaza care descompune colagenul si favorizeaza cresterea
celulelor de cancer
L-Lizina inhiba colagenaza care descompune colagenul si favorizeaza metastaza
canceroasa
31 Vitamina Ccu doza inalta un anti-cancer in tratamentul pacientilor
de cancer unde nu are prioritate citostaticele, studiu randomizat dublu-orb
placebo controlat
Ceai Verde (Camellia Sinensis) - foto
Nutraceutice - Nutraceuticele Anti Aging Systeme sint
din plante naturale: Farmacia Naturala, care au efecte farmaceutice numite
si fitofarmaceutice.
Ceai Verde Supreme cu Flavonoizi, Polifenoli 90%, monomeri sai Catechine extr. stand. 70% - Epicatechingalat,
Epigalocatechin, Epicatechin si EGCG - Galatul de epigalocatechina 50%din: Farmacia Naturala
34CeaiVerde
Supreme cu: Polifenoli 90%, Catechine 70% si EGCG -
Galatul de epigalocatechina extr. stand. 50% are capacitatea de inhibare
de enzima metaloproteinaza matricial -9(MMP-9) (cunoscut ca Gelatinaza
B) si (Gelatinaza A) aceasta enzima detine un rol important pentru
invazia tumorala si metastazarea cancerului
35Extractul EGCG-
Galatul de epigalocatechina extr. stand. 50% inhiba si actioneaza regresia
la celulele de cancer de prostata (PC-3) si cancerul mamar
37Ceai Verde Supreme cu: Polifenoli 90%, Catechine
70% si EGCG - Galatul de epigalocatechina extr. stand.
50% inhiba proteolitic enzima urokinaza si ornitin decarboxilaza, urokinaza
este o enzima de care se foloseste celula de cancer pentru a intra
in tesutul sanatos si a forma metastaze.
38Ceai Verde Supreme cu: Polifenoli 90%, Catechine
70% si EGCG - Galatul de epigalocatechina extr. stand.
50% reduce enzima 5-alfa reductaza este un agent citostatic natural,
inhiba proliferarea celulelor canceroase de prostata
39Ceai Verde Supreme cu: Polifenoli 90%, Catechine
70% si EGCG - Galatul de epigalocatechina extr. stand.
50% inhiba glioblastoma
40Ceai Verde Supreme cu: Polifenoli 90%, Catechine
70% si EGCG - Galatul de epigalocatechina extr. stand.
50% previne riscul de melanom malign (cancer de piele) reduce inflamatia
razelor UVB
Totul despre Diindolylmethane, metabolismul
estrogenului, promovarea reducerii greutatii corporale, control hormonal
Totul despre Diindolylmethane de Dr.
Michael A. Zeligs
41 Receptorul AH se leaga de Indole-3-Carbinol si induce hidroxilarea
estradiolului , in proces de hidroxilare estrogen 2 hidroxilaza (EH)
microzomala (citocrom P450) este involvat receptorul AH
DIM Diindolylmethane cu actiune anti proliferativa
45 Indole-3-Carbinol inhiba expresia ciclin
-dependent kinaza-6 care induce G1 ciclul celular la celulele de cancer
mamar independent de receptorii de estrogen
46 Indole-3-Carbinol reduce incidenta de
cancer mamar, actioneaza asupra receptorii de estrogeni negativi ai celulelor
de cancer mamar
47 Indole-3-Carbinol un anti-cancer inhiba
impreuna cu tamoxifen cancerul mamar la linia celulara MCF-7
48. Indole-3-Carbinol induce apoptoza la cancerul mamar pe linia celulara MCF-7,
reface functia antitumorala a genei p21 si p53
49 Indole-3-Carbinol cu utilitate clinica
in preventia cancerului mamar la linia celulara MCF-7 si alt cancer dependent
hormonal
50 Indole-3-Carbinol cu efect in metabolismul estrogenului
prin cresterea de estrogen 2-hidroxilat, inactiveaza estrogenii endogeni
nefavorabili (17beta-estradiol) si estron, reduce riscul de cancer mamar
51 Indole-3-Carbinol extractul fitofarmaceutic
moduleaza estrogenul, inhiba proliferarea, cu preventie la cancerul mamar
52 Indole-3-Carbinol cu aspect multifunctional
de actiune antitumorala
53 16 alfa hidroxiesteron (16 alpha-OHE1) un initiator, un potential
biomarker al riskului de cancer mamar: are corelatia cu proteina de legatura-3
( growth factor binding protein-3 IGFBP-3)
54 16 alfa hidroxiesteron al estrogenului (estradiol) un posibil risc
marker de cancer mamar
55 Proportia metabolitiilor de estrogen si riscul de cancer hormonal
din lb. gr."homao" inseamna „Eu pun in miscare", de risc al cancerului cervical
56 Indole-3-Carbinol cu efect citostatic la cancerul endometrial
57 Cresterea activitatii de estrogen "16 hidroxilaza" la femei cu cancer mamar si endometrial
58 Cresterea de estrogen 2-hidroxilat la femei cu obezitate dupa consumul
de Indole-3-Carbinol
59 Obezitatea, dieta, metabolismul de estrogen afectat: Dominanta estrogenica cu riscul de cancer hormonal
Dieta anti-estrogenica indicat la cura de slabire, suplimente
nutritive cu specific anti-estrogenic: Indole-3-Carbinol, Resveratrol,
Diindolylmethane, Isoflavone si Prostata Formula
Dieta mediteraneana creste longevitatea, studiile
arata ca populatiile din tarile mediteraneene sint longevivi
60 Dieta mediteraneana traditionala reduce estrogenul endogen la femei
sanatoase in postmenopauza
61Acizii grasi esentiali polinesaturati Omega 3 din Ulei de Peste atenueaza cresterea
cancerului mamar, prin activarea neutrala de mediere a sfingomielinaza
62 Resveratrol un citostatic cu proprietati anti-estrogenice la adenocarcinomul
endometrial
63 Resveratrol un produs natural din struguri cu activitate anti-estrogenica,
inhiba cancerul mamar
64 Resveratrol cu proprietati de anti-estrogen la cancerul mamar pe
linia celulara MCF-7
65 Resveratrol cu proprietati de anti-estrogen la tumora mamara
66 Resveratrol un fitoestrogen cu efect la aromataza 17 beta-hidroxisteroid
dehidrogenaza activitate si la cancerul mamar
67 Resveratrol un polifenol din struguri este un agonist pentru receptorul
de estrogen
68 Resveratrol este un mixt de agonist/antaginist pentru receptorul
alfa si beta al estrogenului
Informatii din bibliografia electronica la tema: Nutritie
si sanatate
1Velicer CM, Ulrich CM. Vitamin and mineral supplement
use among US adults after cancer diagnosis: a systematic review. Fred
Hutchinson Cancer Research Center, Department of Epidemiology, University
of Washington, Seattle, WA 98109, USA. J Clin Oncol. 2008 Feb 1;26(4):665-73.
2 Fletcher RH, Fairfield KM. Vitamins for chronic disease prevention in
adults: clinical applications. Department of Ambulatory
Care and Prevention, Harvard Medical School/Harvard Pilgrim Health Care,
133 Brookline Ave, Sixth Floor, Boston, MA 02215, USA. JAMA. 2002 Jun
19;287(23):3127-9.
- Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults:
scientific review. Division of General Medicine and Primary Care, Beth Israel
Deaconess Medical Center and Channing Laboratory, Department of Medicine, Brigham
and Women's Hospital, Harvard Medical School, Boston, MA, USA. JAMA. 2002 Jun
19;287(23):3116-26.
3 Huang HY, Caballero B, Chang S, Alberg A, Semba R, Schneyer C, Wilson RF,
Cheng TY, Prokopowicz G, Barnes GJ 2nd, Vassy J, Bass EB. Multivitamin/mineral
supplements and prevention of chronic disease. Evid Rep Technol Assess (Full
Rep). 2006 May;(139):1-117.
4 Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol
EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease:
meta-analysis of randomised trials. Department of Cardiovascular Medicine,
Cleveland Clinic Foundation, Cleveland, OH 44195, USA. Lancet. 2003 Jun
14;361(9374):2017-23.
5 Lamm DL, Riggs DR, Shriver JS, vanGilder PF, Rach
JF, DeHaven JI. Megadose vitamins in bladder cancer: a double-blind clinical
trial. J Urol. 1994 Jan;151(1):21-6.
6 Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates
variant enzymes with decreased coenzyme binding affinity (increased K(m)):
relevance to genetic disease and polymorphisms. Department of Molecular and
Cellular Biology, University of California, Berkeley, USA. Am J Clin Nutr.
2002 Apr;75(4):616-58.
7 Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ,
Fuchs C, Rosner BA, Speizer FE, Willett WC. Multivitamin use, folate, and colon
cancer in women in the Nurses' Health Study. Brigham and Women's Hospital,
Harvard Medical School, Boston, Massachusetts, USA. Ann Intern Med. 1998
Oct 1;129(7):517-24.
8 Zhang S, Hunter DJ, Hankinson SE, Giovannucci EL,
Rosner BA, Colditz GA, Speizer FE, Willett WC. A prospective study of folate
intake and the risk of breast cancer. Department of Epidemiology, Harvard
School of Public Health, Boston, Mass, USA. JAMA. 1999 May 5;281(17):1632-7.
9 Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin
D and calcium supplementation reduces cancer risk:
results of a randomized trial. Osteoporosis Research Center, Creighton
University, Omaha, NE 68131, USA. Department of Urology, West Virginia
University School of Medicine, Morgantown. Am J Clin Nutr. 2007 Jun;85(6):1586-91.
10 Rayman MP. Selenium in cancer prevention: a review of the evidence and
mechanism of action. Division of Nutrition, Dietetics and Food, School of Biomedical
and Molecular Sciences, University of Surrey, Guildford, UK. Proc Nutr Soc.
2005 Nov;64(4):527-42.
11 Suzuki F, Brutkiewicz RR, Pollard RB. Importance
ot T-cells and macrophages in the antitumor activity of carboxyethylgermanium
sesquioxide
(Ge-132). Anticancer Research 1985;5(5):479-483.
12 Aso H, Suzuki F, Yamaguchi T, Hayashi Y, Ebina T, Ishida N. Induction of
interferon and activation of NK cells and macrophages in mice by oral administration
of Ge-132, an organic germanium compound. Microbiology and Immunology 1985;29(1):65-74
13 Jang JJ, Cho KJ, Lee YS, Bae JH. Modifying responses of allyl sulfide,
indole-3-carbinol and germanium in a rat multi-organ carcinogenesis model.
Carcinogenesis 1991;4:691-695.
14 Aso H, Suzuki F, Ebina T, Ishida N. Antiviral activity of carboxyethylgermanium
sesquioxide (Ge-132) in mice infected with influenza virus. Department of Bacteriology,
Tohoku University School of Medicine, Sendai, Japan. J Biol Response Mod. 1989
Apr;8(2):180-9.
15 Mainwaring MG, Poor C, Zander DS, Harman E. Complete remission of pulmonary
spindle cell carcinoma after treatment with oral germanium sesquioxide. Department
of Medicine, Divisions of Hematology and Oncology, University of Florida College
of Medicine and Veterinary Affairs Medical Center, Gainesville, FL 32610, USA.
Chest. 2000 Feb;117(2):591-3.
16 Long QC, Zeng GX, Zhao XL. Pharmacokinetics of germanium after po beta-carboxyethylgermanium
sesquioxide in 24 Chinese volunteers. Department of Clinical Pharmacology,
Sun Yat-Sen University of Medical Sciences, Guangzhou, China. Zhongguo Yao
Li Xue Bao. 1996 Sep;17(5):415-8
17 Brutkiewicz RR, Suzuki F. Biological activities and antitumor mechanism
of an immunopotentiating organogermanium compound, Ge-132 (review). Department
of Internal Medicine, University of Texas Medical Branch, Galveston 77550.
In Vivo. 1987 Jul-Aug;1(4):189-203.
18 Suzuki F. Suppression of tumor growth by peritoneal macrophages isolated
from mice treated with carboxyethylgermanium sesquioxide (Ge-132) Gan To Kagaku
Ryoho. 1985 Nov;12(11):2122-8.
19 Suzuki F. Antitumor activity of Ge-132, a new organogermanium compound,
in mice is expressed through the functions of macrophages and T lymphocytes
Gan To Kagaku Ryoho. 1985 Jul;12(7):1445-52.
20 Suzuki F, Brutkiewicz RR, Pollard RB. Cooperation of lymphokine(s) and
macrophages in expression of antitumor activity of carboxyethylgermanium sesquioxide
(Ge-132). Anticancer Res. 1986 Mar-Apr;6(2):177-82.
21Suzuki F. Suppression of tumor growth by peritoneal macrophages isolated
from mice treated with carboxyethylgermanium sesquioxide (Ge-132) Gan To Kagaku
Ryoho. 1985 Nov;12(11):2122-8.
22 Sato I, Yuan BD, Nishimura T, Tanaka N. Inhibition of tumor growth and
metastasis in association with modification of immune response by novel organic
germanium compounds. Journal of Biological Response Modifiers 1985;4(2):159-168.
23 Kumano N, Ishikawa T, Koinumaru S, Kikumoto T, Suzuki S, Nakai Y, Konno
K. Antitumor effect of the organogermanium compound Ge-132 on the Lewis lung
carcinoma (3LL) in C57BL/6 (B6) mice. Tohoku J Exp Med. 1985 May;146(1):97-104.
24 Sato I, Nishimura T, Kakimoto N, Suzuki H, Tanaka N. Prevention of pulmonary
metastasis of Lewis lung carcinoma and activation of murine macrophages by
a novel organic germanium compound, PCAGeS. Biological Response Modifiers 1988;7(1):1-5.
25 Tanaka N, Ohida J, Ono M, et al. Augmentation of NK activity in peripheral
blood lymphocytes of cancer patients by intermittent Ge-132 administration.
Gan To Kagaku Ryoho 1984;11(6):1303-1306.
26 Takeda Y, Tominga T, Tei N, et al. Inhibitory effect of L-arginine on growth
of rat mammary tumors induced by 7,12-dimethlybenz(a)anthracine. Cancer Res
1975;35:23903.
27 Brittenden J, Park KGM, Heys SD, et al. L-arginine stimulates host defenses
in patients with breast cancer. Surgery 1994;115:20512.
28 Imler M, Ruscher H, Peter B et al: The effect of arginine in a case of
recurrent hepatic coma complicating a feminizing cortico-adrenal tumor with
hepatic metastasis. Sem Hop Paris 1973; 49:3183-3190.
29 Park KGM. The immunological and metabolic effects of L-arginine in human
cancer. Proc Nutr Soc 1993;52:387401.
30 Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment
of cancer: Prolongation of survival times in terminal human cancer. Proc Natl
Acad Sci U S A. 1976 Oct;73(10):3685-9.
31 Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. High-dose
vitamin C versus placebo in the treatment of patients with advanced cancer
who have had no prior chemotherapy. A randomized double-blind comparison. N
Engl J Med. 1985 Jan 17;312(3):137-41.
32 Imai K, Suga K, Nagachi K. Cancer-preventive effects of drinking green
tea among a Japanese population. Prev Med. 1997;26(6):769-775.
- Mukhtar H., Ahmad N. Tea polyphenols: prevention of cancer and optimizing
health. Am. J. Clin. Nutr., 71: 1698S-702S, 2000.
- Cao Y., Cao R. Angiogenesis inhibited by drinking tea. Nature (Lond.), 398:
381 1999.
- Brown MD. Green tea (Camellia sinensis) extract and its possible role in
the prevention of cancer. Alt Med Rev. 1999;4(5):360-370.
- Sazuka M, et al. Inhibitory effects of green tea infusion on in vitro invasion
and in vivo metastasis of mouse lung carcinoma cells. Cancer Lett 1995;98:27-31.
33 Sugiyama T, Sadzuka Y. Enhancing effects of green tea components on the
antitumor activity of adriamycin against M5076 ovarian sarcoma. Cancer letters
1998;133:19-26
- Fujiki H, Suganuma M, Okabe S, et al. Cancer inhibition by green tea. Mutation
Research. 1998;307-310.
- Gao Yt, McLaughlin JK, Blot WJ Reduced risk of esophageal cancer associated
with green tea consumption. J Natl Cancer Inst. 1994 Jun 1;86(11):855-8.
- Hirose M. Inhibition of mammary gland carcinogenesis by green tea catechins.
Cancer Lett 1994;83:149-156.
- Inoue M, Tajima K, Mizutani M, et al. Regular consumption of green tea and
the risk of breast cancer recurrence: follow-up study from the Hospital-based
Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer
Lett. 2001;167(2):175-182.
- Kaegi E. Unconventional therapies for cancer: 2. Green tea. [Review]. The
Task Force on Alternative Therapies of the Canadian Breast Cancer Research
Initiative. CMAJ. 1998;158(8):1033-1035.
- Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y. Influence of drinking
green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer
Res. 1998;89(3):254-261.
- Pianetti S, Guo S, Kavanagh KT, Sonenshein GE. Green tea polyphenol epigallocatechin-3
gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype
of breast cancer cells. Cancer Res. 2002;62(3):652-655.
- Setiawan VW, Zhang ZF, Yu GP, et al. Protective effect of green tea on the
risks of chronic gastritis and stomach cancer. Int J Cancer. 2001;92(4):600-604.
- Sano T, Sasako M. Green tea and gastric cancer. N Engl J Med. 2001;344(9):675-676.
- Tsubono Y, Nishino Y, Komatsu S, et al. Green tea and the risk of gastric
cancer in Japan. N Engl J Med. 2001;344(9):632-636.
- Yu GP, Hsieh CC, Wang LY, Yu SZ, Li XL, Jin TH. Green-tea consumption and
risk of stomach cancer: a population-based case-control study in Shanghai,
China. Cancer Causes Control. 1995;6(6):532-538.
- Sugiyama T, Sadzuka Y. Enhancing effects of green tea components on the antitumor
activity of adriamycin against M5076 ovarian sarcoma. Cancer Lett. 1998;133(1):19–26.
- Ji B-T, Chow W-H, Hsing AW, et al. Green tea consumption and the risk of
pancreatic and colorectal cancers. Int J Cancer. 1997;70:255-258.
- Fujiki H, Suganuma M, Okabe S, et al. Mechanistic findings of green tea as
cancer preventive for humans. Proc Soc Exp Biol Med. 1999;220(4):225–228.
- Ahmad N, Mukhtar H. Green tea polyphenols and cancer: biologic mechanisms
and practical implications. Nutr Rev. 1999; 57:78-83.
- Ahmad N, et al. Green tea constituent epigallocathechin-3-gallate and induction
of apoptosis and cell cycle arrest in human carcinoma cells. H Natl Cancer
Inst 1997;89:1881-86.
- Wang Z, et al. Antimutagenic activity of green tea polyphenols. Mutation
Research. 1989;223:273-285.
- Jankun J, et al. Why drinking green tea could prevent cancer. Nature 1997;387:561
- Taniguchi S, et al. Effect of (-)-epigallocatechin gallate, the main constituent
of green tea, on lung metastasis with mouse B16 melanoma cells lines. Cancer
Lett 1992;65:51-4.
-Kaegi E, on behalf of the Task Force on Alternative Therapies of the Canadian
Breast Cancer Research Initiative. Unconventional therapies for cancer: 2.
Green tea. Canadian Medical Association 1998;158:1033-1035.
34 Demeule M, Brossard M, Pagé, M, et al. Matrix metalloproteinase
inhibition by green tea catechins. Biochim Biophys Acta. 2000; 1478:51-60.
35 Liao S, Umekita Y, Guo J, Kokontis JM, Hiipakka RA. Growth inhibition and
regression of human prostate and breast tumors in athymic mice by tea epigallocatechin
gallate. Cancer Lett. 1995;96:239-243.
- Carlin BI, Pretlow TG, Pretlow TP, et al. Green tea polyphenols inhibit growth
of PC xenograft cwr-22 and decrease ornithine decarboxylase activity: implications
for PC chemoprevention. J Urol 155: 510A, 1996.
36 Hu G, Han C, Chen J.Inhibition of oncogene expression by green tea and
(-)-epigallocatechin gallate in mice. Institute of Nutrition and Food Hygiene,
Chinese Academy of Preventive Medicine, Beijing, China. Nutr Cancer. 1995;24(2):203-9.
37 Carlin BI, Pretlow TG, Pretlow TP, et al. Green tea polyphenols inhibit
growth of PC xenograft cwr-22 and decrease ornithine decarboxylase activity:
implications for PC chemoprevention. J Urol 155: 510A, 1996.
38 Liao S, Hipakka, RA. Selective inhibition of steroid 5-alfa-reductase [5AR]
by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochemical and
Biophysical Research Communications; 214(3), 833-838,1995).
- Gupta S, Ahmad N, Mukhtar H. Prostate cancer chemoprevention by green tea.
Semin Urol Oncol. 1999; 17:70-76.
- Suganuma M, Okabe S, Sueoka N, et al. Green tea and cancer chemoprevention.
Mutation Res. 1999; 428:339-344.
- Suganuma M, Okabe S, Kai Y, et al. Synergistic effects of (-)-epigallocatechin
gallate with (-)-epicatechin, sulindac ortamoxifen on cancer-preventive
activity in the human lung cancer cell line PC-9. Cancer Research 1999; 59:
44-47.
39 Sachinidis A, Seul C, Seewald S, et al. Green tea compounds inhibit tyrosine
phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma.
FEBS Lett. 2000; 471:51-55.
40 Katiyar SK, Matsui MS, Elmets CA, Mukhtar H. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate
from green tea reduces UVB-induced inflammatory responses and infiltration
of leukocytes in human skin. Photochem Photobiol 1999;69:148-153.
- Mukhtar H., Katiyar S. K. et al. Green tea and skin: anticarcinogenic effects.
J. Investig. Dermatol. 102: 3-7
41 Jellinck PH, Forkert PG, Riddick DS, Okey AB, Michnovicz JJ, Bradlow HL.
Ah receptor binding properties of indole carbinols and induction of hepatic
estradiol hydroxylation. Department of Biochemistry, Queen's University, Kingston,
Ontario, Canada. Biochem Pharmacol. 1993 Mar 9;45(5):1129-36.
42 Stoewsand GS. Bioactive organosulfur phytochemicals in Brassica oleracea
vegetables-a review. Food Chem Toxicol 1995;33:537-43.
43 Albert-Puleo M. Physiological effects of cabbage with reference to its
potential as a dietary cancer-inhibitor and its use in ancient medicine. J
Ethnopharm. 1983; 9:261-272.
44 Wattenberg LW and Loub WD, Inhibition of polycyclic aromatic hydrocarbon-induced
neoplasia by naturally occurring indoles. Cancer Research 1978; 38:1410-1413.
45 Cover CM, Hsieh SJ, Tran SH, Hallden G, Kim GS, Bjeldanes LF, Firestone
GL. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6
and induces a G1 cell cycle arrest of human breast cancer cells independent
of estrogen receptor signaling. Department of Molecular and Cell Biology and
Cancer Research Laboratory, University of California, Berkeley, California
94720, USA. J Biol Chem. 1998 Feb 13;273(7):3838-47.
46 Riby JE, Feng C, Chang YC, Schaldach CM, Firestone GL, Bjeldanes LF. The
major cyclic trimeric product of indole-3-carbinol is a strong agonist of the
estrogen receptor signaling pathway. Division of Nutritional Sciences and Toxicology,
and Department of Molecular and Cell Biology, University of California, Berkeley,
California 94720, USA. Biochemistry. 2000 Feb 8;39(5):910-8.
- Auborn KJ, Fan S, Rosen EM, Goodwin L, Chandraskaren A, Williams DE, Chen
D, Carter TH. Indole-3-carbinol is a negative regulator of estrogen. North
Shore-Long Island Jewish Research Institute, Manhasset, NY 11030, USA. J Nutr.
2003 Jul;133(7 Suppl):2470S-2475S.
47 Cover CM, Hsieh SJ, Cram EJ, Hong C, Riby JE, Bjeldanes LF, Firestone GL.
Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7
human breast cancer cells. Department of Molecular and Cell Biology and The
Cancer Research Laboratory, The University of California at Berkeley, 94720-3200,
USA. Cancer Res. 1999 Mar 15;59(6):1244-51.
48 Ge
X, Fares FA, Yannai S. Induction of apoptosis in MCF-7 cells by indole-3-carbinol
is independent of p53 and bax. Department of Food Engineering and Biotechnology,
Technion-Israel Institute of Technology, Haifa, Israel. Anticancer Res. 1999
Jul-Aug;19(4B):3199-203
549 Niwa
T, Swaneck G, Bradlow HL. Alterations in estradiol metabolism in MCF-7 cells
induced by treatment with indole-3-carbinol and related compounds. Steroids.
1994; 59:523-527.
50 Bradlow
HL, et al. 1991. Effects of dietary indole-3-carbinol on estradiol metabolism
and spontaneous mammary tumors in mice. Carcinogenesis 12:1571-74.
- Bradlow HL, Michnovicz J, Telang NT, Osborne MP. Effects of dietary indole-3-carbinol
on estradiol metabolism and spontaneous mammary tumors in mice. Institute for
Hormone Research, New York, NY 10016. Carcinogenesis. 1991 Sep;12(9):1571-4.
521 Telang
NT, et al., Inhibition of proliferation and modulation of estradiol metabolism:
novel mechanisms for breast cancer prevention by the phytochemical
indole-3-carbinol. Proceedings of the Society for Experimental Biology and
Medicine 1997; 216: 246-252.
52 Bradlow
HL, Sepkovic DW, Telang NT, Osborne MP. Multifunctional aspects of the action
of indole-3-carbinol as an antitumor agent. Ann NY Acad Sci.
1999; 889:204-213.
53 Ho
GH, et al. Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum
insulin-like growth factor binding protein-3 and a potential biomarker
of breast cancer risk. Ann Acad Med Singapore 1998; 27:294-299.
54 Bradlow
HL, et al., 16a hydroxylation of estradiol: a possible risk marker for breast
cancer. Annals NY Acad. Sci. 1986; 464: 138-151.
55 Sepkovic
DW, et al., Estrogen metabolite ratios and risk assessment of hormone related
cancers: assay validation and prediction of cervical cancer
risk. Annals of the N.Y. Acad. of Science 1995; 768: 312-316.
56 Kojima
T., et al., Chemoprevention of spontaneous endometrial cancer in female donryu
rats by dietary indole-3-carbinol. Cancer Research 1994; 54:
1446-1449.
57 Fishman,
J, et al., Increased estrogen -16-hydroxylase activity in women with breast
and endometrial cancer. Journal of Steroid Biochem. and Mol. Biol.
1984; 20: 1077-1081.
58 Michnovicz
JJ. 1998. Increased estrogen 2- hydroxylation in obese women using oral indole-3-carbinol.
Int J Obes Relat Metab Disord 22:227-9.
59 Hershcopf
RJ, Bradlow HL. Obesity, diet, endogenous estrogens, and the risk of hormone-sensitive
cancer. Am J Clin Nutr. 1987 Jan;45(1 Suppl):283-9.
60 Carruba
G, Granata OM, Pala V, et al. A traditional Mediterranean diet decreases endogenous
estrogens in healthy postmenopausal women. Nutr Cancer.
2006;56(2):253-9.
61 Wu
M, Harvey KA, Ruzmetov N, et al. Omega-3 polyunsaturated fatty acids attenuate
breast cancer growth through activation of a neutral sphingomyelinase-mediated
pathway. Int J Cancer. 2005 Nov 10;117(3):340-8.
62 Bhat
KP, Pezzuto JM. Resveratrol exhibits cytostatic and antiestrogenic properties
with human endometrial adenocarcinoma (Ishikawa) cells. Program
for Collaborative Research in the Pharmaceutical Sciences and Department of
Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois
at Chicago, Chicago, Illinois 60612, USA. Cancer Res. 2001 Aug 15;61(16):6137-44.
63 Lu,
R., and Serrero, G. Resveratrol, a natural product derived from grape, exhibits
antiestrogenic activity and inhibits the growth of human breast cancer
cells. J. Cell. Physiol., 179: 297304, 1999.
64 Matsumura
A, Ghosh A, Pope GS, Darbre PD. "Comparative study of oestrogenic
properties of eight phytoestrogens in MCF7 human breast cancer cells." J
Steroid Biochem Mol Biol. 2005 Apr;94(5):431-43.
65 Bhat
KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM. Estrogenic and antiestrogenic
properties of resveratrol in mammary tumor models. Program
for Collaborative Research in the Pharmaceutical Sciences, Department of Medicinal
Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at
Chicago, Chicago, Illinois 60612, USA. Cancer Res. 2001 Oct 15;61(20):7456-63.
66 Le
Bail, J. C., Champavier, Y., Chulia, A. J., and Habrioux, G. Effects of phytoestrogens
on aromatase, 3 and 17-hydroxysteroid dehydrogenase activities
and human breast cancer cells. Life Sci., 66: 12811291, 2000.
67 Gehm
BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound
found in grapes and wine, is an agonist for the estrogen receptor.
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern
University Medical School, 303 E. Chicago Avenue, Chicago, IL 60611, USA. Proc
Natl Acad Sci U S A. 1997 Dec 9;94(25):14138-43.
68 Bowers
JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Resveratrol acts as a mixed agonist/antagonist
for estrogen receptors alpha and beta. Department
of Biochemistry and Molecular Biology, University of Louisville School of Medicine,
Kentucky 40292, USA. Endocrinology. 2000 Oct;141(10):3657-67.
- Levenson AS, Gehm BD, Pearce ST, Horiguchi J, Simons LA, Ward JE 3rd, Jameson
JL, Jordan VC. Resveratrol acts as an estrogen receptor (ER) agonist in breast
cancer cells stably transfected with ER alpha. Robert H Lurie Comprehensive
Cancer Center, The Feinberg School of Medicine, Northwestern University, Chicago,
IL 60611, USA. Int J Cancer. 2003 May 1;104(5):587-96.
69 Potter
GA, Patterson LH, Wanogho E, Perry PJ, Butler PC, Ijaz T, Ruparelia KC, Lamb
JH, Farmer PB, Stanley LA, Burke MD. The cancer preventative agent
resveratrol is converted to the anticancer agent piceatannol by the cytochrome
P450 enzyme CYP1B1. Cancer Drug Discovery Group, School of Pharmacy, De Montfort
University, The Gateway, Leicester LE1 9BH, UK. Br J Cancer. 2002 Mar 4;86(5):774-8.
70 Grubbs
CJ, et al. 1995. Chemoprevention of chemically-induced mammary carcinogenesis
by indole-3-carbinol. Anticancer Res 15:709-16.
71 Kassie
F, Anderson LB, Scherber R, Yu N, Lahti D, Upadhyaya P, Hecht SS. Indole-3-carbinol
inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo(a)pyrene-induced
lung tumorigenesis in A/J mice and modulates carcinogen-induced alterations
in protein levels. Cancer Center, University of Minnesota, Minneapolis,
Minnesota 55455, USA. Cancer Res. 2007 Jul 1;67(13):6502-11.
72Manson,
M.M., Hudson, E.A., Ball, H.W., Barrett, M.C., Clark, H.L., Judah, D.J.,
Verschoyle, R.D. and Neal, G.E. (1998) Chemoprevention of aflatoxin B1-induced
carcinogenesis by indole-3-carbinol in rat liver - predicting the outcome
using
early biomarkers. Carcinogenesis, 19, 1829-36.
73 Chang
YC, Riby J, Chang GH, Peng BC, Firestone G, Bjeldanes LF. Cytostatic and
antiestrogenic effects of 2-(indol-3-ylmethyl)-3,3'-diindolylmethane, a
major in vivo product of dietary indole-3-carbinol. Division of Nutritional
Sciences and Toxicology, University of California, Berkeley 94720, USA.
Biochem Pharmacol. 1999 Sep 1;58(5):825-34.
74 He
YH, et al. 1997. Chemopreventive properties of indole-3-carbinol (I3C):
inhibition of DNA adduct formation of the dietary carcinogen, 2-amino-1-methyl-6-pehnylimidazo
[4,5-b]pyridine (PhIP), in female F344 rats. J Cell Biochem Suppl 27:42-51.
75 Munday
R, Mhawech-Fauceglia P, Munday CM, Paonessa JD, Tang L, Munday JS, Lister
C, Wilson P, Fahey JW, Davis W, Zhang Y. Inhibition of urinary bladder
carcinogenesis by broccoli sprouts. AgResearch Limited, Ruakura Agricultural
Research Center, Hamilton, New Zealand. Cancer Res. 2008 Mar 1;68(5):1593-600.
Epub 2008 Feb 29.
76 Chen
DZ, Qi M, Auborn KJ, Carter TH. Indole-3-carbinol and diindolylmethane
induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic
preneoplastic cervical epithelium. North Shore-Long Island Jewish Research
Institute, Manhasset, NY 11030, USA. J Nutr. 2001 Dec;131(12):3294-302.
77 Jin
L, Qi M, Chen DZ, Anderson A, Yang GY, Arbeit JM, Auborn KJ. Indole-3-carbinol
prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic
mice. Department of Otolaryngology, Long Island Jewish Medical Center,
The Long Island Campus of Albert Einstein College of Medicine, New Hyde
Park,
New York 11040, USA. Cancer Res. 1999 Aug 15;59(16):3991-7.
78 Rosen
CA, Woodson GE, Thompson JW, Hengesteg AP, Bradlow HL. Preliminary results
of the use of indole-3-carbinol for recurrent respiratory papillomatosis.
Department of Otolaryngology--Head and Neck Surgery, University of Pittsburgh
Medical Center, Pennsylvania, USA. Otolaryngol Head Neck Surg. 1998 Jun;118(6):810-5.
79 E.
S. Ginsburg, N. K. Mello, J. H. Mendelson, R. L. Barbieri, S. K. Teoh,
M. Rothman, X. Gao and J. W. Sholar Effects of alcohol ingestion on estrogens
in postmenopausal women Department of Obstetrics and Gynecology, Brigham
and
Women's Hospital, Boston, MA 02115, USA. JAMA Vol. 276 No. 21, December
4,
1996; 276:1747-51.
80 Morse
MA, LaGreca SD, Amin SG, Chung FL. Effects of indole-3-carbinol on lung
tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
(NNK) and on the metabolism and disposition of NNK in A/J mice. Section
of
Nucleic Acid Chemistry, Naylor Dana Institute for Disease Prevention, American
Health Foundation, Valhalla, New York. Cancer Res. 1990 May 1;50(9):2613-7.
81 Nachshon-Kedmi
M, Yannai S, Haj A, Fares FA. Indole-3-carbinol and 3,3'-diindolylmethane
induce apoptosis in human prostate cancer cells. Faculty of Food Engineering
and Biotechnology, Technion- Israel Institute of Technology, 32000, Haifa,
Israel. Food Chem Toxicol. 2003 Jun;41(6):745-52.
82 Frydoonfar
HR, McGrath DR, Spigelman AD. The effect of indole-3-carbinol and sulforaphane
on a prostate cancer cell line. Discipline of Surgical Science,
Faculty of Health, The University of Newcastle, New South Wales, Australia.
ANZ J Surg. 2003 Mar;73(3):154-6.
Parerea din pasajele acestui site nu a fost independent
cercetate sau confirmate
Anticancer-Oncoxin cu Germaniu Organic (GE-132) in activitatea anticancer la activarea importanta de macrofage si celulele T.
Anti-Cancer
Anticancer
Anti-Aging-Systeme
- 
